Man Group’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $27M | Buy |
51,382
+16,857
| +49% | +$9.46M | 0.04% | 406 |
|
|
2026
Q1 | $19.4M | Buy |
34,525
+9,113
| +36% | +$5.84M | 0.04% | 512 |
|
|
2025
Q4 | $17.2M | Buy |
25,412
+2,866
| +13% | +$1.95M | 0.03% | 574 |
|
|
2025
Q3 | $14.4M | Sell |
22,546
-37,292
| -62% | -$22.6M | 0.03% | 632 |
|
|
2025
Q2 | $32.1M | Buy |
59,838
+14,729
| +33% | +$7.04M | 0.06% | 350 |
|
|
2025
Q1 | $18.9M | Buy |
45,109
+4,315
| +11% | +$1.87M | 0.05% | 462 |
|
|
2024
Q4 | $16.9M | Sell |
40,794
-45,244
| -53% | -$19.8M | 0.04% | 502 |
|
|
2024
Q3 | $43.5M | Sell |
86,038
-112,147
| -57% | -$54.5M | 0.11% | 227 |
|
|
2024
Q2 | $96.6M | Buy |
198,185
+41,787
| +27% | +$21M | 0.24% | 84 |
|
|
2024
Q1 | $84.4M | Buy |
156,398
+120,569
| +337% | +$65.9M | 0.21% | 103 |
|
|
2023
Q4 | $19.9M | Buy |
+35,829
| New | +$16.8M | 0.06% | 408 |
|
|
2023
Q3 | – | Sell |
-123,419
| Closed | -$61.5M | – | 297 |
|
|
2023
Q2 | $62M | Buy |
+123,419
| New | +$59.1M | 0.19% | 115 |
|
|
2023
Q1 | – | Sell |
-4,342
| Closed | -$2.08M | – | 975 |
|
|
2022
Q4 | $1.77M | Sell |
4,342
-22,238
| -84% | -$8.63M | 0.01% | 1150 |
|
|
2022
Q3 | $8.66M | Buy |
+26,580
| New | +$9.76M | 0.04% | 520 |
|
|
2022
Q2 | – | Sell |
-130,081
| Closed | -$53M | – | 433 |
|
|
2022
Q1 | $71.2M | Buy |
130,081
+45,410
| +54% | +$23.9M | 0.25% | 86 |
|
|
2021
Q4 | $55.8M | Buy |
84,671
+17,813
| +27% | +$11.2M | 0.18% | 117 |
|
|
2021
Q3 | $41.6M | Buy |
66,858
+29,497
| +79% | +$19.8M | 0.15% | 152 |
|
|
2021
Q2 | $23.6M | Sell |
37,361
-1,235
| -3% | -$682K | 0.08% | 263 |
|
|
2021
Q1 | $18.9M | Sell |
38,596
-4,909
| -11% | -$2.46M | 0.08% | 257 |
|
|
2020
Q4 | $21.7M | Sell |
43,505
-62,059
| -59% | -$27.8M | 0.1% | 208 |
|
|
2020
Q3 | $41.5M | Buy |
105,564
+55,330
| +110% | +$20.5M | 0.16% | 128 |
|
|
2020
Q2 | $16.6M | Sell |
50,234
-135,563
| -73% | -$39.3M | 0.08% | 230 |
|
|
2020
Q1 | $45M | Sell |
185,797
-204,290
| -52% | -$53.3M | 0.29% | 73 |
|
|
2019
Q4 | $102M | Buy |
390,087
+4,806
| +1% | +$1.27M | 0.34% | 54 |
|
|
2019
Q3 | $105M | Sell |
385,281
-26,341
| -6% | -$7.33M | 0.39% | 45 |
|
|
2019
Q2 | $113M | Sell |
411,622
-75,175
| -15% | -$18.5M | 0.41% | 34 |
|
|
2019
Q1 | $109M | Buy |
486,797
+45,712
| +10% | +$9.44M | 0.41% | 41 |
|
|
2018
Q4 | $82M | Buy |
441,085
+123,232
| +39% | +$25.3M | 0.37% | 46 |
|
|
2018
Q3 | $79.4M | Buy |
317,853
+86,173
| +37% | +$20.9M | 0.29% | 56 |
|
|
2018
Q2 | $50.5M | Buy |
231,680
+158,769
| +218% | +$32.7M | 0.21% | 89 |
|
|
2018
Q1 | $14M | Buy |
+72,911
| New | +$13.5M | 0.06% | 343 |
|
Other funds holding IDXX
Man Group's IDXX Position: Q2 2026 in Review
Man Group increased its Idexx Laboratories (IDXX) stake by 49% in Q2 2026, buying an estimated $9.46M and bringing the position to 51,382 shares worth $27M. The position accounts for 0.04% of the portfolio, ranked #406.
Man Group first reported a position in IDXX in Q1 2018 and has held it in 31 quarters since. The position peaked at $113M in Q2 2019. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Man Group held 51,382 shares of Idexx Laboratories worth $27M as of Q2 2026.
- Man Group bought 16,857 Idexx Laboratories shares in Q2 2026, an estimated $9.46M.
- Idexx Laboratories made up 0.04% of Man Group's portfolio in Q2 2026, its #406 holding.
- Man Group first reported a position in Idexx Laboratories in Q1 2018 and has held it in 31 quarters since.
- Man Group's Idexx Laboratories position peaked at $113M in Q2 2019.
- 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.